Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03579901 · ClinicalTrials.gov registry record · NA
Study of the Safety and Effectiveness of Motiva Implants®
A NA study of Breast Implants, sponsored by Motiva USA.
- Active
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 20
- Study locations
NCT03579901: Active NA study of Breast Implants, sponsored by Motiva USA.
NCT03579901 is a NA study of Breast Implants that is active but no longer recruiting, run by Motiva USA. The registered enrollment target is 800 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03579901, a NA study of Breast Implants, is active but no longer recruiting, sponsored by Motiva USA.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study evaluates the safety and effectiveness Motiva Implants® in women who are undergoing primary breast augmentation, primary breast reconstruction or revision breast surgery.
Conditions Studied
Interventions
- DEVICE Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants
Study Locations (20)
New York
- Mark D. Epstein, MD, FACS/ Center for Aesthetic Surgery - Hauppauge
- NYU Plastic Surgery Associates - New York
- May Center for Mount Sinai Doctors - New York
- Fifth Avenue Millennium Aesthetic Surgery, PLLC - New York
California
- Gerald Minitti, MD, FACS - Beverly Hills
- Steven Teitelbaum, MD, FACS - Santa Monica
- Westlake Cosmetic Surgery Center - Westlake Village
Illinois
- Northwestern Plastic Surgery - Chicago
- Northwestern Specialists in Plastic Surgery, S.C. - Chicago
Oregon
- Movassaghi Plastic Surgery & Ziba Medical Spa - Eugene
- Portland Plastic Surgery - Portland
Colorado
- The Center for Cosmetic Surgery - Golden
Georgia
- Emory University Hospital - Atlanta
Indiana
- Meridian Plastic Surgery Center - Indianapolis
Kentucky
- CaloAesthetics® Plastic Surgery Center - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2018-04-06 |
| Est. Completion | 2033-02-28 |
| Phase | NA |
What the registry record for NCT03579901 still lists
NCT03579901 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Breast Implants appearing as the primary indexed condition, and to 1 intervention - of which Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants is the first listed.
NCT03579901 names 20 study sites across 13 states, led by New York, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT03579901 about?
NCT03579901 is a clinical study titled "Study of the Safety and Effectiveness of Motiva Implants®". This study evaluates the safety and effectiveness Motiva Implants® in women who are undergoing primary breast augmentation, primary breast reconstruction or revision breast surgery.
What is the current status of trial NCT03579901?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2018-04-06. Estimated completion is 2033-02-28.
What conditions does trial NCT03579901 study?
This clinical trial studies the following conditions: Breast Implants.
What interventions are being tested in trial NCT03579901?
The interventions under investigation include: Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants (DEVICE).
Who is sponsoring clinical trial NCT03579901?
This trial is sponsored by Motiva USA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03579901 being conducted?
This trial has 20 study locations across California, Colorado, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03579901's enrollment target sits among peer trials
800 135th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI